Related by context. All words. (Click for frequent words.) 69 antibody 69 mAbs 68 XmAb# 68 MAb 67 humanized antibody 67 HuMax CD# 66 monoclonal antibody 65 adenoviral 65 Onconase 65 T#I [002] 65 Nanobody 65 MAbs 64 VEGF receptor 64 AEG# 64 PEGylated 64 HuLuc# 64 rhIL 7 64 monoclonal antibodies 64 siRNA therapeutic 64 IgG1 antibody 64 chimeric monoclonal antibody 63 Nanobodies 63 humanized monoclonal antibody 63 therapeutic antibody 63 DXL# 63 Tarvacin 63 murine monoclonal antibody 63 monoclonal antibody mAb 63 kinase inhibitors 63 anti CD3 63 CD# antibody [001] 63 Nanobody ® 63 thrombopoietin 63 A3 adenosine receptor 63 IMA# 63 humanized monoclonal antibodies 62 IFN alpha 62 Anticalin 62 protein kinase inhibitor 62 EndoTAG TM -1 62 Nanobodies ® 62 nanoviricides 62 JVRS 62 CD# antibodies 62 milatuzumab 62 JAK inhibitor 62 BiTE 62 Annexin V 62 EGFr 62 dAbs 62 BAL# [001] 62 DOS# 62 CD# monoclonal antibody 62 therapeutic monoclonal antibodies 62 CXCR4 receptor 62 monoclonal 62 antibody fragment 62 epitope 62 anticancer therapies 62 OncoVEX 62 Debio 62 OMP #M# 62 immunotoxin 62 molecularly targeted 62 tumor antigen 62 preclinically 62 HCV 62 antibodies 62 targeting CD# 62 CCX# 62 oral antiviral 61 ESBA# 61 solithromycin 61 alpha#beta# integrin 61 therapeutic monoclonal antibody 61 IFN gamma 61 TG# [003] 61 IgG1 61 SERMs 61 Panzem 61 XmAb 61 NS4A 61 OncoVEX GM CSF 61 drug conjugate 61 proteolytic cleavage 61 splice variant 61 polymerase inhibitors 61 immunomodulator 61 cancer immunotherapies 61 PSMA ADC 61 Alferon N 61 Micromet BiTE 61 ENMD # 61 MEK inhibitor 61 siRNA 61 neutralizing antibody 61 intratumoral injection 61 VAX# 61 monoclonal antibodies mAbs 61 integrin receptors 61 Pertuzumab 61 polyclonal antibody 61 interferon IFN 61 oligonucleotide therapeutics 61 HCV replicon 61 HCV protease inhibitors 61 chemically modified siRNA 61 Xanafide 61 PDGF 61 cytostatic 61 Zolinza 61 Olaparib 61 Sphingomab 60 Tarvacin TM 60 Factor VIIa 60 PI3K inhibitor 60 FLT3 60 humanized antibodies 60 human monoclonal antibody 60 monoclonal antibody MAb 60 p# biomarker 60 IRX 2 60 immune stimulatory 60 otelixizumab 60 humanized monoclonal 60 PTP 1B 60 small molecule inhibitors 60 Antibody 60 EpCAM 60 Interferon alpha 60 K RAS 60 DP b# 60 eIF4E 60 delta isoform 60 EGFRvIII 60 isotype 60 JAK3 60 Symadex 60 siRNA therapeutics 60 OvaRex R 60 prophylactic vaccines 60 synthetic peptide 60 Anticalin R 60 Aplidin 60 HDACi 60 fusion inhibitor 60 monoclonals 60 bispecific antibody 60 RAV# 60 peptide antigens 60 replicon 60 PLX# 60 antibody MAb 60 KinomeScan 60 viral antigens 60 TNFa 60 serine protease 60 obatoclax 60 effector function 60 RhuDex ® 60 Monoclonal Antibody 60 P#X# 60 thymalfasin 60 Radilex 60 polyclonal 60 nicotinic acetylcholine receptor 60 vidofludimus 60 huC# DM4 60 colon carcinoma 60 ATL# [001] 60 MVA BN R 60 HIV protease 60 aT cell 60 MT#/MEDI-# 60 murine 60 Omacetaxine 60 antisense drug 60 plasma kallikrein 60 effector functions 60 Survivin 59 S/GSK# 59 Tarvacin Anti Viral 59 HQK 59 GHRH 59 deacetylase inhibitors 59 Azedra 59 oncolytic 59 liposomal formulation 59 GV# [001] 59 gefitinib Iressa 59 rxRNA 59 PXD# 59 PORxin TM 59 GM CSF 59 OHR/AVR# 59 cilengitide 59 indibulin 59 TNF α 59 investigational humanized monoclonal antibody 59 antitumor 59 TLR agonists 59 G CSF 59 humanized anti 59 anti CD# antibody 59 Multimeric 59 thymidylate synthase TS 59 PEGPH# 59 Stapled Peptide 59 uPA 59 proteasome inhibitor 59 PEG Interferon lambda 59 Vidofludimus 59 S#P# 59 INGN 59 novel peptide 59 epothilones 59 topoisomerase 59 survivin 59 sclerostin 59 JAK2 inhibitors 59 lentiviral vector 59 chimeric antibodies 59 Gleevec resistant 59 torezolid 59 predictive biomarkers 59 flavopiridol 59 vivo 59 soluble receptor 59 IMC A# 59 VEGFR2 59 alpha interferon 59 activin 59 Carfilzomib 59 oral prodrug 59 glycosylated 59 recombinant protein 59 Vitaxin 59 Anticalin ® 59 Cathepsin S 59 Fc fusion protein 59 HuMax CD4 59 Anticalins 59 metaglidasen 59 elotuzumab 59 vascular disrupting agents 59 HyACT 59 epothilone 59 bispecific 59 JAK inhibitors 59 Blinatumomab 59 oncolytic virus 59 PI3 kinase 59 HER3 59 DepoVax 59 pomalidomide 59 vitro assay 59 Lpathomab 59 LB# [003] 59 EGFR 59 TH# cells 59 cytotoxic 59 PRX# 59 TAp# 59 Sym# 59 SIRT2 59 Milatuzumab 59 INCB# [001] 59 GPR# [002] 59 HIF 1a 59 IGF 1R 59 therapeutic antibodies 59 nucleoside analogues 59 CytoFabTM 59 Panzem R NCD 59 PDGF B 59 glioma cells 59 FGFR 59 BNC# 59 pharmacokinetic interactions 58 antiviral compounds 58 PROCHYMAL 58 anti EGFR antibody 58 heterologous 58 CCR9 58 induce apoptosis 58 transfection reagent 58 NEUGENE 58 cytotoxics 58 ASONEP 58 tyrosine kinase inhibitor 58 HCV protease 58 peptide 58 isoform selective 58 PRT# 58 siRNA mediated 58 BCR ABL inhibitors 58 c MET 58 daclizumab 58 deforolimus 58 AtuRNAi 58 TNFα 58 peptidomimetic 58 Fc receptor 58 LEX System 58 proteasome inhibitors 58 Interferon alfa 58 EGF receptor 58 TNFalpha 58 virotherapy 58 Anticalins ® 58 factor Xa 58 HCV polymerase 58 epigenetic therapeutics 58 NEUGENE antisense 58 CCR5 inhibitor 58 fusion protein 58 MAPK pathway 58 REP# 58 anti CD# antibodies 58 AAV2 58 PARP inhibitor 58 immunomodulatory 58 PEGylated interferon 58 CGEN # 58 Homspera 58 BCR ABL 58 monoclonal antibody therapeutics 58 MUC1 58 interleukin IL -# 58 Anticalins R 58 GRN#L 58 outer membrane proteins 58 anticancer agent 58 polymerase inhibitor 58 XmAb ® 58 pDCs 58 Kahalalide F 58 ErbB3 58 ALN TTR 58 GRNVAC1 58 affinity antibodies 58 C5aR 58 Proxinium TM 58 L asparaginase 58 TLR9 agonist 58 CCR5 antagonist 58 Davanat 58 FluCide 58 Guanilib 58 immunotherapeutic 58 AVI NEUGENE 58 #ME# 58 Gastrointestinal Stromal Tumors 58 selective inhibition 58 TLR8 58 PI3K inhibitors 58 Elotuzumab 58 favorable pharmacokinetic profile 58 DNA plasmid 58 PDE4 inhibitor 58 recombinant albumin 58 anti angiogenic agent 58 Angiocept 58 p# inhibitors 58 CHO cells 58 PARP inhibition 58 TLR9 58 MORAb 58 factor VIIa 58 annexin 58 UPLYSO 58 IMPDH 58 novel peptides 58 protein tyrosine phosphatase 1B 58 HCV polymerase inhibitor 58 osteoclast 58 EndoTAG TM 58 PEG SN# 58 HGS# 58 BAY #-# 58 inhibit viral replication 58 tumorigenic 58 aptamer 58 HDAC 58 Elvitegravir 58 Notch1 58 HBV vaccine 58 integrase inhibitor 58 nucleotide analogues 58 mTOR inhibitors 58 tolevamer 58 IFN γ 58 non nucleoside HCV 58 TG# [001] 58 cytotoxic T lymphocyte 58 MyVax R 58 Bortezomib 58 Liposomal 58 BRAF mutation 58 immune modulating 58 antisense oligonucleotide 58 glucagon receptor 58 antitumoral 58 anthrax toxin 58 CYT# 58 allogeneic cell 58 Eg5 58 histone deacetylase HDAC 58 keratinocyte 58 Trastuzumab 58 murine mouse 58 elacytarabine 58 Xencor XmAb 58 Amplimexon 58 personalized immunotherapy 58 GeoVax vaccine 58 TroVax 58 HuCAL antibodies 58 plasmid DNA vaccine 58 PKC isoforms 58 Traficet EN 58 EGFR HER 58 decitabine 58 potent cytotoxic 58 adenoviral vector 58 Epratuzumab 58 Ii protein 58 Monoclonal antibodies 58 PARP inhibitors 58 TTR gene 58 OXi# 58 lentiviral vectors 58 mertansine 57 CDDO Im 57 CRAC channel 57 hTERT 57 pro angiogenic 57 REMUNE R 57 RNAi therapeutic 57 vorinostat 57 Golimumab 57 M1 muscarinic 57 TLR9 agonists 57 inflammatory cytokine 57 cMET 57 reslizumab 57 immunostimulatory 57 rituximab Rituxan 57 IAP inhibitor 57 anti CD3 monoclonal 57 gp# [002] 57 CD#b 57 immunogens 57 splice variants 57 Ridaforolimus 57 transgene expression 57 MEK inhibitors 57 ceftazidime 57 hepatoma 57 PDGF receptor 57 talabostat 57 antisense oligonucleotides 57 anti TNF 57 miR #a [002] 57 davunetide intranasal AL 57 adenoviral vectors 57 orally bioavailable 57 PLX cells 57 investigational monoclonal antibody 57 CCR9 antagonist 57 Locked Nucleic Acid LNA 57 Leukine ® 57 CK2 57 phosphorylcholine 57 Panitumumab 57 apoptosis inducing 57 recombinant antibodies 57 Pancreate 57 HSP# inhibitor 57 synthetic peptides 57 HGS ETR1 57 targeted radiotherapeutic 57 HuMax EGFr 57 BiovaxID 57 LEAPS TM 57 RGB # 57 CXCR4 57 ADAMTS# 57 IMP# 57 Tyrima 57 c MYC 57 CR# vcMMAE 57 bendamustine 57 targeted antifolate 57 Angiolix 57 therapeutics 57 Belerofon 57 CDK inhibitor 57 FUS1 57 SAR# [002] 57 systemically administered 57 GAP #B# 57 FVIIa 57 vemurafenib 57 SGLT 57 Fc gamma receptor 57 PKM2 57 Aurora kinase 57 HCD# [002] 57 biobetter 57 SGLT 2 57 Dalbavancin 57 IMC #B 57 GPR# [001] 57 bactericidal activity 57 EndoTAG 57 Velcade bortezomib 57 protein tyrosine phosphatase 57 Archexin 57 antiangiogenic therapy 57 preclinical 57 immune modulatory 57 humanised monoclonal antibody 57 Scancell 57 THR beta agonist 57 pegylated 57 antiproliferative activity 57 clinically validated targets 57 LY# [003] 57 antisense drugs 57 busulfan 57 DNA gyrase 57 HDAC inhibition 57 small molecule 57 lentiviral 57 monoclonal antibodies MAbs 57 hA# 57 GW# [003] 57 MUC1 * 57 Aganocide 57 DermaVir 57 Daclizumab 57 MET amplification 57 BRAF kinase 57 M2 subunit 57 Insegia 57 beta interferons 57 PSN# [002] 57 paclitaxel Taxol 57 NNRTIs 57 iRGD 57 Novavax VLP vaccine 57 Imprime PGG 57 macrophage colony stimulating 57 exosome 57 PRTX 57 Aptamer 57 pradefovir 57 depsipeptide 57 ZFP TF 57 IFN g 57 systemic antifungal 57 NeuroVax TM 57 NS4B 57 soluble tumor necrosis 57 CCR5 antagonists 57 neuraminidase inhibitor 57 HER2/neu 57 ON #.Na 57 Arcalyst 57 CCR5 inhibitors 57 Curaxin 57 mapatumumab 57 CD# [002] 57 fusion proteins 57 CD4 + T lymphocytes 57 chemotherapy induced neutropenia 57 synthetic siRNA 57 NS5A 57 Septin 9 57 Lodamin 57 tubulin inhibitor 57 Valortim ® 57 VZV 57 nucleotide analogs 57 interferons 57 selective modulator 57 EGFR receptor 57 optimized siRNA 57 Factor IX 57 Janus Kinase 57 renin inhibitors 57 ganetespib 57 epigenetic therapies 57 MDV# 57 gamma secretase inhibitors 57 tumorigenicity 57 Vorinostat 57 Akt activation 57 ectodomain 57 kinase inhibition 57 protein kinase inhibitors 57 LPA1 57 receptor tyrosine kinase inhibitor 57 transfected cells 57 nucleoside 57 xenograft models 57 CEQ# 57 ganciclovir 57 Flt3 57 SPC# [001] 57 OncoVex 57 interferon lambda 57 Squalamine 57 myeloma cells 57 liposomal 57 H#N# VLP vaccine 57 MGCD# [001] 57 VLPs 57 pertuzumab 57 PKC# 57 antiviral therapies 57 IL2 57 lumiliximab 57 IL #E 57 Ofatumumab 57 IFN α 57 integrase 57 Vilazodone 57 TGF beta1 57 Litx 57 anticancer therapeutics 57 shRNA 57 ONCONASE 57 vivo validation 57 Pradefovir 57 #beta HSD 1 57 CobaCyte 57 KRAS mutation 57 nutlin 57 cytotoxicity assays 57 polyclonal antibodies 57 Tesetaxel 57 LHRH 57 mda 7 57 nucleoside analogs 57 Campath ® 57 cathepsin K inhibitor 57 HuCAL PLATINUM 56 cellular cytotoxicity 56 iSONEP 56 immatics 56 GPCR 56 sCD# 56 Ceflatonin 56 Aflibercept 56 recombinants 56 hepatocyte 56 Corgentin 56 kinase inhibitor 56 epitopes 56 imatinib Gleevec 56 Apo2L 56 induces apoptosis 56 antigen 56 biologic therapies 56 CD#L 56 TGF ß 56 TRAIL receptor 56 bacterial enzyme 56 Trofex 56 trans splicing 56 methylated DNA 56 proteinase 56 JAK2 56 E1A 56 Marqibo TM 56 Fodosine 56 tumor antigens 56 micro RNA 56 Spiegelmer 56 PI3K/mTOR 56 pan HDAC inhibitor 56 receptor monoclonal antibody 56 Urocidin 56 zanolimumab 56 prophylactic vaccine 56 recombinant factor VIIa 56 anticancer therapy 56 dacetuzumab 56 Janus kinase 56 immunized mice 56 LSD1 56 oral dnaJP1 56 AMPK activators 56 glycosylation profile 56 rhIGFBP 3 56 muscarinic 56 GFT# 56 TPI ASM8 56 Cethromycin 56 anticancer activity 56 camptothecin 56 antagomirs 56 tumor necrosis 56 antibody arrays 56 HDAC inhibitor 56 biologic therapeutics 56 PGE2 56 inhibit EGFR 56 HuCAL antibody 56 preclinical studies 56 Genentech Rituxan 56 tyrosine phosphorylation 56 Nedd4 56 Clusterin 56 C5a 56 PDE# inhibitors 56 benzimidazole 56 NOD mice 56 Cytotoxic 56 Tofacitinib 56 cathepsins 56 Epothilones 56 ALK inhibitors 56 T#I mutant 56 pegylated liposomal doxorubicin 56 XOMA 3AB 56 nanoviricide 56 EGFR pathway 56 Micromet proprietary BiTE 56 Mucosal 56 gastrin 56 XL# XL# 56 Immunohistochemical analysis 56 bioactive lipids 56 recombinant erythropoietin 56 PRLX # 56 DermaVir Patch 56 TNF alpha inhibitors 56 Hsp# inhibitor 56 ISTODAX 56 Chemokine Receptor 56 GSK3B 56 ribosomal proteins 56 recombinant adeno associated 56 neutralizing antibodies 56 omacetaxine 56 Phylomer 56 receptors EGFR 56 siRNA sequences 56 antitumor effect 56 vascular disrupting 56 CBLC# 56 antiangiogenic 56 peptides 56 cytotoxin 56 dSLIM 56 YONDELIS 56 pathophysiological effects 56 IgG antibodies 56 HuCAL 56 ALN TTR# 56 Ganciclovir 56 orally dosed 56 ANAVEX #-# [001] 56 lysophosphatidic acid LPA 56 NY ESO 56 CTLA 4 56 phage display 56 Medarex UltiMAb R 56 immunological responses 56 methylnaltrexone 56 Fleximer 56 Hemopurifier ® 56 annexin V 56 E#F# 56 RECOTHROM R 56 iNOS 56 non nucleoside 56 secretory pathway 56 zileuton 56 HCV protease inhibitor 56 androgen receptor AR 56 CD4 receptor 56 tranilast 56 potent antitumor activity 56 Dasatinib 56 erlotinib Tarceva 56 Ramoplanin 56 Pazopanib 56 enzastaurin 56 resolvin 56 IGF IR 56 apoptotic cells 56 CD8 responses 56 HuMax TAC 56 VEGF Trap 56 5 HT2B receptor 56 Tumor Necrosis Factor 56 kinase profiling 56 virulence genes 56 Anavex #-# 56 immuno modulatory 56 investigational antibody 56 protease 56 Monoclonal antibody 56 XmAb ™ 56 TACI Ig 56 molecular biomarkers 56 EZN 56 Wnt signaling pathway 56 nicotinic alpha 7 56 NPM1 56 murine antibodies 56 proprietary phage display 56 JAK#/JAK# 56 multitargeted 56 SynCon TM DNA 56 CD# ligand 56 VSV G 56 DepoVax ™ 56 nucleoside analogue 56 volociximab 56 LEUKINE 56 elvucitabine 56 plasmid encoding 56 ACZ# 56 veltuzumab 56 NSCLC tumors 56 Prolastin A1PI 56 TGF Beta 56 Kevetrin 56 CLORETAZINE TM VNP#M 56 vascular disrupting agent 56 atacicept 56 ACTCellerate 56 immunotoxins 56 Ceftaroline 56 biomarker 56 inhibit replication 56 AV HALT 56 FK# 56 interferon γ 56 VivaGel TM 56 IAP inhibitors 56 anticancer agents 56 Dapagliflozin 56 Myocet 56 siRNAs targeting 56 eotaxin 56 Neugene 56 HIV integrase inhibitors 56 angiogenesis inhibitor 56 Genentech Roche 56 infected macrophages 56 Hemopurifier 56 IL #R 56 CIMZIA ™ 56 panobinostat 56 ProNAi 56 ADME 56 Preclinical studies suggest 56 Aethlon Hemopurifier R 56 ribonuclease 56 kallikrein 56 druggable targets 56 EndoTAGTM 1 56 CCR2 56 Anthim 56 AKT inhibitor 56 Cytotoxic T 56 ChemoCentryx 56 HyperAcute 56 Enzastaurin 56 TLR7 56 HER2 antibody 56 virosome 56 Mipomersen 56 bardoxolone 56 bleomycin 56 AP# [003] 56 chemokine receptor 56 chemotherapeutic drug 56 JAK2 inhibitor 56 Nanobodies R 56 RRM1 56 PlGF 56 ETBs 56 HTS assay 56 ABRAXANE ® 56 novel topoisomerase 56 cytotoxicity 56 Rituximab 56 menadione 56 glioblastoma cells 56 DepoVax TM 56 Hsp# [002] 56 delipidation 56 selective orally bioavailable 56 cationic lipid 56 Chemetics R 56 inhibitor RG# 56 M2e 56 Dendreon Provenge 56 MVA BN 56 dsDNA 56 Virulizin ® 56 ATL# [002] 56 clusterin 56 AAV vector 56 NOD SCID mice 56 PBMCs 56 investigational therapies 56 intradermal injection 56 antiapoptotic 56 HuMax 56 PEP# [003] 56 investigational protease inhibitor 56 cannabinor 56 alpha folate receptor 56 Alfacell proprietary ribonuclease 56 potent antiproliferative 56 Santaris 56 anti TNF alpha 56 rifamycins 56 cytokines IL 56 anti angiogenic drugs 56 XmAb TM 56 glucocorticoid receptor 56 oncoprotein 56 prostacyclin receptor 56 antiviral efficacy 56 Oncaspar 56 miR #b [002] 56 prodrug 56 imetelstat 56 uricase 56 CTGF 56 multiple myeloma MM 56 anti CD3 antibody 56 Bavituximab 56 outlicensing 56 TRAIL induced apoptosis 56 poly ADP ribose polymerase 56 IL 1ß 56 immunomodulators 56 CD1d 56 HCV replication 56 macrolide antibiotics 56 CCR1 56 nanomedicines 56 Epidermal Growth Factor Receptor 56 chemoresistance 56 LNP formulations 56 Japanese Encephalitis vaccine 55 CCL# 55 small molecule tyrosine 55 dexpramipexole 55 Fc receptors 55 Cytolin R 55 CDK inhibitors 55 ceftaroline 55 Pralatrexate 55 viral genomes 55 cathepsin B 55 enveloped viruses 55 interleukins 55 Antigenics QS 55 c myc 55 anticancer compounds 55 NS#/#A protease 55 novel anticancer 55 MicroRNA 55 Restanza 55 Spiegelmers 55 HER1 55 TKB# 55 oral Factor Xa 55 TransVax tm 55 glatiramer 55 nanomolar 55 GPNMB 55 anti tubercular 55 developing TB4 55 TRAIL R2 55 CYC# 55 selective adenosine 55 transfection reagents 55 Allovectin 7 R 55 Vaxfectin 55 liposomal doxorubicin 55 Universal Flu Vaccine 55 recombinant 55 uPAR 55 CG# [003] 55 ActivX 55 rHuPH# 55 endogenous ligands